Elevated serum levels of interleukin-10 in patients with metastatic malignant melanoma - PubMed (original) (raw)
Elevated serum levels of interleukin-10 in patients with metastatic malignant melanoma
W Dummer et al. Melanoma Res. 1995 Feb.
Abstract
Interleukin-10 (IL-10), originally described as a product of TH2 cell clones, has been recognized as a potential immunosuppressive cytokine. To investigate the relevance of IL-10 in melanoma patients in vivo, we studied IL-10 serum levels in 104 untreated patients in different stages of the disease; 20 healthy subjects and 22 patients with inflammatory dermatoses served as controls. Serum levels were measured by ELISA. Only one of 31 patients with stage I melanoma (3%) and one of 16 stage II patients (6%) showed detectable IL-10 levels. Interestingly, six of 17 patients with lymph node metastases (stage III, 35%) and 29 of 40 patients with widespread disease (stage IV, 73%) revealed IL-10 levels of 15-480 pg/ml. No healthy person and only one control patient had a detectable IL-10 serum level. The data suggest that IL-10 in melanoma patients may contribute to down-modulation of anti-tumour responses in vivo.
Similar articles
- Comparison of serum interleukin-10 (IL-10) levels between normal volunteers and patients with advanced melanoma.
Nemunaitis J, Fong T, Shabe P, Martineau D, Ando D. Nemunaitis J, et al. Cancer Invest. 2001;19(3):239-47. doi: 10.1081/cnv-100102550. Cancer Invest. 2001. PMID: 11338880 - Serum S100--a marker for disease monitoring in metastatic melanoma.
Henze G, Dummer R, Joller-Jemelka HI, Böni R, Burg G. Henze G, et al. Dermatology. 1997;194(3):208-12. doi: 10.1159/000246103. Dermatology. 1997. PMID: 9187834 - Immunologic escape and angiogenesis in human malignant melanoma.
Redondo P, Sánchez-Carpintero I, Bauzá A, Idoate M, Solano T, Mihm MC Jr. Redondo P, et al. J Am Acad Dermatol. 2003 Aug;49(2):255-63. doi: 10.1067/s0190-9622(03)00921-6. J Am Acad Dermatol. 2003. PMID: 12894074 - Heterogenous S-100B protein expression patterns in malignant melanoma and association with serum protein levels.
Bánfalvi T, Udvarhelyi N, Orosz Z, Gergye M, Gilde K, Tímár J. Bánfalvi T, et al. Oncology. 2003;64(4):374-9. doi: 10.1159/000070296. Oncology. 2003. PMID: 12759535 - Significance of plasma cytokine levels in melanoma patients with histologically negative sentinel lymph nodes.
Porter GA, Abdalla J, Lu M, Smith S, Montgomery D, Grimm E, Ross MI, Mansfield PF, Gershenwald JE, Lee JE. Porter GA, et al. Ann Surg Oncol. 2001 Mar;8(2):116-22. doi: 10.1007/s10434-001-0116-3. Ann Surg Oncol. 2001. PMID: 11258775
Cited by
- LPA suppresses HLA-DR expression in human melanoma cells: a potential immune escape mechanism involving LPAR1 and DR6-mediated release of IL-10.
Major E, Lin KH, Lee SC, Káldi K, Győrffy B, Tigyi GJ, Benyó Z. Major E, et al. Acta Pharmacol Sin. 2024 Aug 26. doi: 10.1038/s41401-024-01373-x. Online ahead of print. Acta Pharmacol Sin. 2024. PMID: 39187677 - A peptide derived from interleukin-10 exhibits potential anticancer activity and can facilitate cell targeting of gold nanoparticles loaded with anticancer therapeutics.
Chang CC, Yang CH, Chuang CH, Jiang SJ, Hwang YM, Liou JW, Hsu HJ. Chang CC, et al. Commun Chem. 2023 Dec 15;6(1):278. doi: 10.1038/s42004-023-01079-x. Commun Chem. 2023. PMID: 38102207 Free PMC article. - A Reconstructed Human Melanoma-in-Skin Model to Study Immune Modulatory and Angiogenic Mechanisms Facilitating Initial Melanoma Growth and Invasion.
Michielon E, López González M, Stolk DA, Stolwijk JGC, Roffel S, Waaijman T, Lougheed SM, de Gruijl TD, Gibbs S. Michielon E, et al. Cancers (Basel). 2023 May 20;15(10):2849. doi: 10.3390/cancers15102849. Cancers (Basel). 2023. PMID: 37345186 Free PMC article. - Systemic LRG1 Expression in Melanoma is Associated with Disease Progression and Recurrence.
Hoefsmit EP, Völlmy F, Rozeman EA, Reijers ILM, Versluis JM, Hoekman L, van Akkooi ACJ, Long GV, Schadendorf D, Dummer R, Altelaar M, Blank CU. Hoefsmit EP, et al. Cancer Res Commun. 2023 Apr 20;3(4):672-683. doi: 10.1158/2767-9764.CRC-23-0015. eCollection 2023 Apr. Cancer Res Commun. 2023. PMID: 37089863 Free PMC article. - Mesenchymal-Stromal Cell-like Melanoma-Associated Fibroblasts Increase IL-10 Production by Macrophages in a Cyclooxygenase/Indoleamine 2,3-Dioxygenase-Dependent Manner.
Çakır U, Hajdara A, Széky B, Mayer B, Kárpáti S, Mezey É, Silló P, Szakács G, Füredi A, Pós Z, Érsek B, Sárdy M, Németh K. Çakır U, et al. Cancers (Basel). 2021 Dec 7;13(24):6173. doi: 10.3390/cancers13246173. Cancers (Basel). 2021. PMID: 34944793 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical